Skip to content

Clinical trials

Phase 2 Generalized Anxiety Disorder trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Generalized Anxiety Disorder Phase: Phase 2 Country / region: United States Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20041
20051
20061
20084
20121
20141
20212
20221
20231
20243
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Recruiting5
Active, not recruiting1
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie2
AstraZeneca2
Intra-Cellular Therapies, Inc.2
University of Florida2
Biotie Therapies Inc.1
Brigham and Women's Hospital1
Cybin IRL Limited1
Definium Therapeutics US, Inc.1
Engrail Therapeutics INC1
New York State Psychiatric Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Generalized Anxiety Disorder21
Anxiety Disorders8
Phobia, Social3
Anxiety, Separation2
Alcoholism1
Major Depressive Disorder1
Mental Disorders1
Mood Disorders1
Obsessive-Compulsive Disorder1
Panic Disorder1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.